FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection

Wednesday, May 11, 2011 General News
Email Print This Page Comment
Font : A-A+

Fluzone® Intradermal (Influenza Virus Vaccine) first to offer an immunization option with 90 percent smaller needle

Contacts:

US Media Relations

Global Media Relations

Donna Cary

Pascal Barollier

T. +1-570-957-0717

T. +33-(0)4-37-37-50-38

donna.cary@sanofipasteur.com  

pascal.barollier@sanofipasteur.com

www.sanofipasteur.us

www.sanofipasteur.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook